Venetia, PA, United States of America

Leslie R J Virany

This inventor holds 1 USPTO granted patent. Top assignee: Regear Life Sciences Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leslie R J Virany. Retrieved from https://idiyas.com/inventor/leslie-r-j-virany

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Leslie R J Virany

Introduction

Leslie R J Virany is an accomplished inventor based in Venetia, PA, known for his contributions to therapeutic technology. He has developed a unique diathermy applicator garment that addresses common issues faced in medical treatments.

Latest Patents

Virany holds a patent for a diathermy applicator garment. This innovative device minimizes the risk of burning patients' skin, a frequent concern in diathermy treatments. The design incorporates a specific spatial characteristic of RF stimulation, which is essential for effective heat distribution while preventing unwanted capacitive effects.

Career Highlights

Virany's career is marked by his dedication to improving patient safety and comfort through innovative medical devices. His work at Regear Life Sciences Inc. showcases his commitment to advancing therapeutic technologies.

Collaborations

Virany collaborates with Robert M Unetich, contributing to the development of cutting-edge medical solutions.

Conclusion

Leslie R J Virany's innovative work in the field of diathermy exemplifies the importance of safety and efficacy in medical treatments. His contributions continue to impact the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…